Sangamo Therapeutics Correlations
SGMO Stock | USD 1.17 0.04 3.54% |
The current 90-days correlation between Sangamo Therapeutics and Editas Medicine is 0.04 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sangamo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sangamo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Sangamo Therapeutics Correlation With Market
Good diversification
The correlation between Sangamo Therapeutics and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Sangamo |
Moving together with Sangamo Stock
Moving against Sangamo Stock
0.63 | INKT | Mink Therapeutics Upward Rally | PairCorr |
0.42 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
0.35 | BPMC | Blueprint Medicines Corp | PairCorr |
0.61 | AVAL | Grupo Aval | PairCorr |
0.48 | CIB | Bancolombia SA ADR Trending | PairCorr |
0.39 | MNPR | Monopar Therapeutics | PairCorr |
Related Correlations Analysis
0.88 | 0.1 | 0.59 | -0.87 | EDIT | ||
0.88 | 0.17 | 0.42 | -0.73 | NTLA | ||
0.1 | 0.17 | 0.27 | -0.31 | BLUE | ||
0.59 | 0.42 | 0.27 | -0.62 | ALNY | ||
-0.87 | -0.73 | -0.31 | -0.62 | IMGN | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sangamo Stock performing well and Sangamo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sangamo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EDIT | 3.94 | (1.24) | 0.00 | (1.36) | 0.00 | 7.02 | 35.85 | |||
NTLA | 3.69 | (1.01) | 0.00 | (0.60) | 0.00 | 5.18 | 22.98 | |||
BLUE | 7.24 | 0.58 | 0.04 | (0.23) | 8.60 | 14.85 | 145.15 | |||
ALNY | 1.81 | (0.12) | 0.00 | (0.19) | 0.00 | 4.37 | 15.40 | |||
IMGN | 5.45 | 3.06 | 1.08 | (4.31) | 1.44 | 8.32 | 141.41 |
Sangamo Therapeutics Corporate Management
Phillip Ramsey | Head Operations | Profile | |
David Ojala | Scientist Research | Profile | |
Mark McClung | Ex COO | Profile | |
Stephanie CLP | Head Management | Profile | |
Whitney Jones | VP Officer | Profile | |
Andrew Ramelmeier | Ex Operations | Profile |